Article
PI3Kδ inhibition supports memory T cells with enhanced antitumor fitness
2017-07-20
Abstract excerpt
<h4>SUMMARY</h4> Phosphatidylinositol-3-kinase p110δ (PI3Kδ) inhibition by Idelalisib (CAL-101) in hematological malignancies directly induces apoptosis in cancer cells and disrupts immunological tolerance by depleting regulatory T cells (Tregs). Yet, little is known about the direct impact of PI3Kδ blockade on effector T cells from CAL-101 therapy. Herein, we demonstrate a direct effect of p110δ inactivation via...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b5dd937e-9bfe-57ea-a09d-eca7e5553cc8
- DOI
- 10.1101/166074
